4//SEC Filing
Davis Blaine 4
Accession 0001453687-24-000027
CIK 0001453687other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 5:08 PM ET
Size
7.3 KB
Accession
0001453687-24-000027
Insider Transaction Report
Form 4
Davis Blaine
Chief Financial Officer
Transactions
- Award
Common Stock
2024-01-02+2,424,000→ 2,424,000 total - Award
Employee Stock Option (right to buy)
2024-01-02+3,110,000→ 3,110,000 totalExercise: $0.66Exp: 2034-01-01→ Common Stock (3,110,000 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on January 2, 2025. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2028.
- [F2]This option vests as to 25% on January 2, 2025. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2028.
Documents
Issuer
Cartesian Therapeutics, Inc.
CIK 0001453687
Entity typeother
Related Parties
1- filerCIK 0001802188
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 5:08 PM ET
- Size
- 7.3 KB